Asthma News

WASHINGTON — Compared with white, Asian and Hispanic children, African American children more frequently visited the ED because of asthma or a food allergy, according to study findings.

A medium inhaled corticosteroid dose plus a long-acting beta agonist was found to be the most beneficial step-up treatment option for children with uncontrolled asthma, according to a meta-analysis published in European Respiratory Journal.

WASHINGTON — Allergic status did not impact annualized asthma exacerbation rate reductions seen with mepolizumab, benralizumab and tezepelumab in patients with moderate to severe, uncontrolled asthma, according to study results.

WASHINGTON —Tertiary care center providers generally reported similar asthma inhaler practices despite being from different disciplines, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

A high risk for asthma in children was linked to increased levels of fine particulate matter and nitrogen dioxide exposure in the first 3 years of life, according to results published in JAMA Network Open.

Between dupilumab, benralizumab and mepolizumab, patients with difficult-to-control asthma had the lowest rate of exacerbations in the first year of dupilumab, according to results published in Annals of the American Thoracic Society.

WASHINGTON — Among children with asthma, poor disease control was linked to receipt of food stamps and trouble affording medication, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Individuals who died due to asthma had high levels of total IgE and perennial aeroallergen-specific IgE, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Among children with allergic asthma, disease severity between those with vs. without a COVID-19 infection in 2020 was similar when assessed after 3 years, according to study results.

WASHINGTON — Showing more improvement in bronchodilator responsiveness testing was linked to more exacerbations, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.